Abstract

BackgroundThe perioperative use of biologic DMARDs in patients with rheumatoid arthritis (RA) has potential risks for delayed wound healing and infectious complications. Surgeons are recommended to discontinue biologic DMARDs to...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
308. Surgical site infection after lumbar fusion surgery: risk factors and the preventive new technology
Xie En
The Spine Journal | VOL. 19
Xie EnXie En
22 Aug 2019
Risk Factors for Surgical Site Infection after Major Breast Operation
Jill R Dietz ... Margaret A Olsen
Journal of the American College of Surgeons | VOL. 207
Jill R Dietz, et. al.Jill R Dietz ... Margaret A Olsen
26 Jun 2008
Surgical Site Infection Following Surgery for Inflammatory Bowel Disease in Patients with Clean‐Contaminated Wounds
Naohiro Tomita ... Yoshio Takesue
World Journal of Surgery | VOL. 33
Naohiro Tomita, et. al.Naohiro Tomita ... Yoshio Takesue
07 Feb 2009
1242. Evaluation of Risk Factors for Development of Total Hip Arthroplasty (THA) Surgical Site Infections (SSI)
Jennifer Flaherty ... Mark Lustberg
Open Forum Infectious Diseases | VOL. 6
Jennifer Flaherty, et. al.Jennifer Flaherty ... Mark Lustberg
23 Oct 2019
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers